7,581.75

+7.50

+0.10%

52,637.00

+139.00

+0.26%

27,991.00

-23.50

-0.08%

Russell 2000 Futures

2,852.20

+3.50

+0.12%

4.8640

+0.0050

+0.10%

19.92

-5.72

-22.31%

4,120.70

+6.20

+0.15%

74,726.04

-35.10

-0.05%

Crude Oil Dec 26

85.98

-0.87

-1.00%

US Private Equity

10,850.15

+89.25

+0.83%

NasdaqCM - Nasdaq Real Time Price USD

InMed Pharmaceuticals Inc. (INM)

15.56 +2.56 (+19.65%)

At close: November 6 at 4:00:01 PM EST

Loading Chart for INM

Chart Range Bar

Interval:

In partnership with ChartIQ

Mentari Therapeutics Announces Closing of Merger with InMed Pharmaceuticals and Previously Announced $490 Million Financing

Mentari Therapeutics Announces Closing of Merger with InMed Pharmaceuticals and Previously Announced $490 Million Financing

Mentari Therapeutics to Present at Upcoming Investor Conferences

Mentari Therapeutics to Present at Upcoming Investor Conferences

Fox-Roku’s $22B Deal, A New Nasdaq Biotech And A $25B Chemicals Tie-Up: Deals Investors Are Watching

Fox-Roku’s $22B Deal, A New Nasdaq Biotech And A $25B Chemicals Tie-Up: Deals Investors Are Watching

InMed Pharmaceuticals Completes Closing of Merger with Mentari Therapeutics

InMed Pharmaceuticals Completes Closing of Merger with Mentari Therapeutics

InMed Announces Expected Closing of Merger and Commencement of Trading on Nasdaq Under the Name

InMed Announces Expected Closing of Merger and Commencement of Trading on Nasdaq Under the Name "Mentari Therapeutics, Inc." and Ticker Symbol "MTRI"

InMed Announces Results of 2026 Annual General and Special Meeting, Approval of Corporate Name Change and Completion of Share Consolidation

InMed Announces Results of 2026 Annual General and Special Meeting, Approval of Corporate Name Change and Completion of Share Consolidation

InMed Reports First Quarter Fiscal 2027 Financial Results and Provides Corporate Update

InMed Announces Share Consolidation in Connection with Proposed Merger

InMed Announces Share Consolidation in Connection with Proposed Merger

InMed Pharmaceuticals Regains Compliance with Nasdaq Continued Listing Requirements

InMed Pharmaceuticals Regains Compliance with Nasdaq Continued Listing Requirements

INM Stock Alert: What to Know as InMed, Mentari Announce Merger

INM Stock Alert: What to Know as InMed, Mentari Announce Merger

/C O R R E C T I O N -- InMed Pharmaceuticals/

/C O R R E C T I O N -- InMed Pharmaceuticals/

Mobilize your Website

View Site in Mobile | Classic

Share by: